Master service agreement

Blue Star Foods Secures Additional Non-Dilutive Growth Capital to Support Expansion of Business Under Existing Master Service Agreement & Soft Shell Crab Operations

Retrieved on:

星期三, 四月 17, 2024

Master service agreement, Biophysical environment, RAS, Blue star, ESG, BSFC, Market, Letter, Security (finance)

On April 16, 2024 Blue Star entered into a securities purchase agreement with an accredited investor pursuant to which Blue Star issued a promissory note in the principal amount of $300,000 and 500,000 shares of its restricted common stock.

Key Points:

On April 16, 2024 Blue Star entered into a securities purchase agreement with an accredited investor pursuant to which Blue Star issued a promissory note in the principal amount of $300,000 and 500,000 shares of its restricted common stock.
The promissory note is due May 15, 2024 and can be extended up to 90 days.
On the same date, Blue Star also issued a convertible promissory note to an institutional investor, in the principal amount of $138,000.
Our efforts call for increased working capital support, which we have initially secured through promissory notes.

Blue Star Foods Signs Agreement with Eagle Rising to Provide High-Quality, Nutritious Meals for U.S. Military

Retrieved on:

星期三, 四月 10, 2024

MSA, Meal, Woman, Master service agreement, Biophysical environment, RAS, Partnership, Military personnel, Career, Service-Disabled Veteran-Owned Small Business, ESG, BSFC, Nutrient, SDVOSB, Blue star, Eagle

Miami, FL, April 10, 2024 (GLOBE NEWSWIRE) -- Blue Star Foods Corp., (“Blue Star,” the “Company,” “we,” “our” or “us”) (NASDAQ: BSFC), a leader in value-added meal solutions and an integrated Environmental, Social, and Governance (ESG) sustainable seafood company with a focus on Recirculatory Aquaculture Systems (RAS), is profoundly honored to announce the successful execution of a supply agreement to provide manufacturing of Eagle Rising specified innovative food solutions for the U.S. Military under the support of our recently established Master Service Agreement (MSA). This pivotal agreement facilitates the provision of premium products distributed under the renowned Eagle Rising Brand, a Service-Disabled Veteran-Owned Small Business (SDVOSB), directly supporting the brave men and women serving in the United States military.

Key Points:

This pivotal agreement facilitates the provision of premium products distributed under the renowned Eagle Rising Brand, a Service-Disabled Veteran-Owned Small Business (SDVOSB), directly supporting the brave men and women serving in the United States military.
The agreement encompasses the rollout of thirteen meticulously crafted meal options, each designed to meet the rigorous nutritional standards and diverse preferences of military personnel.
Key Highlights of the Agreement:
Patriotic Partnership: Our collaboration with the Eagle Rising Brand signifies a shared commitment to supporting our troops.
By providing them with meals that resonate with the quality and integrity of the Eagle Rising Brand, we are together honoring their service and sacrifice.

Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing Services

Retrieved on:

星期一, 四月 8, 2024

Max Planck Society, Attention, CDMO, Growth, MSA, Master service agreement, CGMP, Laboratory, Drug development, Administration, Pharmaceutical industry

Under the MSA, Scinai will provide drug development and cGMP manufacturing services, including aseptic filling and quality assurance, to Ayana, including encapsulating drug substances of various partners of Ayana into Ayana's proprietary liposomal drug delivery system.

Key Points:

Under the MSA, Scinai will provide drug development and cGMP manufacturing services, including aseptic filling and quality assurance, to Ayana, including encapsulating drug substances of various partners of Ayana into Ayana's proprietary liposomal drug delivery system.
Ayana COO Yanir Aldouby, commented, "After an extensive search, we are pleased to have selected Scinai Bioservices as our CDMO for our future projects.
We were particularly attracted to the team's experience in bio-pharmaceutical drug development and manufacturing for clinical trials while meeting stringent international regulatory requirements.
As Scinai is also in the business of biological drug development, we believe they understand our needs as a small biopharma company.

Verde Clean Fuels, Inc. Reports Third Quarter 2023 Earnings

Retrieved on:

星期一, 十一月 13, 2023

Verde Clean Fuels, Inc. (“Verde”) (Nasdaq: VGAS), a company focused on becoming leading supplier of gasoline and other fuels derived from renewable feedstocks or natural gas, today reported third quarter 2023 GAAP diluted loss per share of $(0.13).

Key Points:

Verde Clean Fuels, Inc. (“Verde”) (Nasdaq: VGAS), a company focused on becoming leading supplier of gasoline and other fuels derived from renewable feedstocks or natural gas, today reported third quarter 2023 GAAP diluted loss per share of $(0.13).
Verde has entered into a Master Services Agreement (MSA) with Anacapa Engineering and Design to support Verde through the California permitting process and the accompanying Environmental Impact Report for our Elk Hills Project.
Verde has commenced the selection process for FEED/EPC services for the Verde – Cottonmouth Ventures plant in the Permian Basin.
Verde expects to enter into a FEED contract upon the completion of its Joint Development Agreement with Cottonmouth Ventures.

ISC Reports 2023 Third Quarter Financial Results

Retrieved on:

星期三, 十一月 8, 2023

REGINA, Saskatchewan, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Information Services Corporation (TSX:ISV) (“ISC” or the “Company”) today reported on the Company’s financial results for the third quarter ended September 30, 2023.

Key Points:

REGINA, Saskatchewan, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Information Services Corporation (TSX:ISV) (“ISC” or the “Company”) today reported on the Company’s financial results for the third quarter ended September 30, 2023.
Adjusted free cash flow for the quarter was $14.4 million, up 27 per cent compared to $11.4 million in the third quarter of 2022, primarily related to stronger results from operations in Registry Operations and Services during the quarter.
The Consolidated Net Funded Debt to EBITDA financial covenant was increased to provide additional balance sheet flexibility to ISC.
On July 27, 2023, ISC announced that it has expanded the lenders under the Company’s Credit Facility to include the Bank of Montreal.

Trust Stamp Provides a Business Report and Financial Results for the Quarter and Period Ended September 30, 2023 Including Positive EBITDA for Q3

Retrieved on:

星期二, 十一月 7, 2023

Atlanta, GA, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI), the Privacy-First Identity Company™ providing AI-powered trust and identity services used globally across multiple sectors, announced financial results and provided a business update for the quarter and period ended September 30, 2023 (“Q3 2023”).

Key Points:

Atlanta, GA, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI), the Privacy-First Identity Company™ providing AI-powered trust and identity services used globally across multiple sectors, announced financial results and provided a business update for the quarter and period ended September 30, 2023 (“Q3 2023”).
As of the date of this filing, Trust Stamp has staffed five Orchestration Layer account executives.
Research and development (“R&D”) expenses decreased by $173 thousand, or 22.19% for Q3 2023, compared to Q3 2022.
Selling, general, and administrative expense (“SG&A”) decreased by $1.23 million, or 37.42%, for Q3 2023, compared to Q3 2022.

Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics

Retrieved on:

星期一, 十月 30, 2023

MSA, NMPA, TP53, Hope, Boehringer Ingelheim, National Medical Products Administration, Master service agreement, Research, Rock, Partnership, Cancer, LSE, BTC, Safety, Patient, Pharmaceutical industry, Water Drops on Burning Rocks

GUANGZHOU, China, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”) is pleased to announce that the Company and Boehringer Ingelheim officially have signed the Master Service Agreement (MSA) in the field of oncology companion diagnostics.

Key Points:

GUANGZHOU, China, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”) is pleased to announce that the Company and Boehringer Ingelheim officially have signed the Master Service Agreement (MSA) in the field of oncology companion diagnostics.
This partnership will primarily focus on advancing the clinical trials related to Boehringer Ingelheim's MDM2-p53 antagonist, brigimadlin (BI 907828), and the development of companion diagnostic products in China.
Mr. Yusheng Han, Founder and CEO of Burning Rock, expressed, “We are delighted to establish a deep collaboration in companion diagnostics with Boehringer Ingelheim.
Burning Rock has a comprehensive layout and supports companion diagnostics development with a global perspective for pharmaceutical companies.

Skillful Craftsman Education Technology Limited Announces Collaboration with Prestige to Supply Healthcare Talents to Singapore

Retrieved on:

星期四, 十月 26, 2023

Prestige, Education, Nursing, Master service agreement, Workforce, Partnership, Singaporeans

WUXI, China, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Skillful Craftsman Education Technology Limited ("Skillful Craftsman" or "Company") (NASDAQ: EDTK), a pioneering education technology company that offers interactive online learning services, is excited to announce a strategic collaboration between its Singapore subsidiary, Le First Skilland Pte.

Key Points:

WUXI, China, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Skillful Craftsman Education Technology Limited ("Skillful Craftsman" or "Company") (NASDAQ: EDTK), a pioneering education technology company that offers interactive online learning services, is excited to announce a strategic collaboration between its Singapore subsidiary, Le First Skilland Pte.
This partnership aims to facilitate the sourcing of qualified Chinese healthcare professionals that Prestige will place with Singaporean hospitals.
The collaborative efforts of Skilland and Prestige are not limited to addressing the current healthcare workforce deficit in Singapore.
Skillful Craftsman and Skilland are committed to the development of a robust, sustainable healthcare workforce that can effectively meet the evolving needs of Singapore's healthcare industry," concluded Mr. Fu.

RespireRx Pharmaceuticals Inc.’s Subsidiary ResolutionRx Ltd Enters into Master Services Agreement for Dronabinol Manufacturing and Related Services

Retrieved on:

星期四, 十月 12, 2023

Master service agreement, Partnership, CSO, MSA, Dronabinol, RespireRx, GMP, OTC Markets Group, Obstructive sleep apnea, Australian Company Number, Pharmaceutical industry

The initial services relate to ResolutionRx’s repurposing of dronabinol and its development program for obstructive sleep apnea pursuant to which Ab Initio will, among other things, manufacture and test our new dronabinol lipid nanoparticle formulation for pharmacokinetic, pharmacodynamic, and pivotal clinical trials, as well as ultimately for commercialization.

Key Points:

The initial services relate to ResolutionRx’s repurposing of dronabinol and its development program for obstructive sleep apnea pursuant to which Ab Initio will, among other things, manufacture and test our new dronabinol lipid nanoparticle formulation for pharmacokinetic, pharmacodynamic, and pivotal clinical trials, as well as ultimately for commercialization.
“The importance of this partnership cannot be overstated,” said Arnold Lippa, Ph.D., co-CEO and CSO of ResolutionRx and CEO and CSO of RespireRx.
“With its formulation expertise and GMP manufacturing facilities, Ab Initio will complete our original laboratory experiments to determine a final, optimum dronabinol formulation, scale up and manufacture the chosen formulation for clinical use.
The lipid nanoparticle technology not only represents a major step forward in the development of dronabinol, but the potential for more widespread use for insoluble or poorly soluble drugs.”

Meta Materials and Panasonic Industry Collaborate on Next Generation Transparent Conductive Materials

Retrieved on:

星期五, 九月 29, 2023

META, NOVA, Exhibition, Electronics, CEATEC, EMI, Metamaterial, Master service agreement, Growth, ADAS, Research, Ceramic, Cassette tape

This joint effort is expected to strengthen the supply of NANOWEB(R) films and accelerate the growth of the transparent conductive film industry, offering new applications for the automotive and consumer electronics sectors, such as transparent film antennas, transparent film heaters, and transparent film electromagnetic shielding.

Key Points:

This joint effort is expected to strengthen the supply of NANOWEB(R) films and accelerate the growth of the transparent conductive film industry, offering new applications for the automotive and consumer electronics sectors, such as transparent film antennas, transparent film heaters, and transparent film electromagnetic shielding.
We have selected Panasonic Industry to mass produce our patented designs due to their outstanding process technology, coupled with their automotive-grade quality, which supports our common goal to expand the transparent conductive materials sector," stated George Palikaras, President and CEO of META.
The collaboration between META and Panasonic Industry combines the design power of NANOWEB(R) metal mesh designs with Panasonic Industry's leading proprietary and scalable process technology in transparent conductive films.
Panasonic Industry and Meta Materials will be showcasing at the Panasonic Industry booth at CEATEC 2023, Japan's leading comprehensive technology exhibition, from October 17 to 20, 2023.